chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with ...

chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company’s primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those ...

ABL Bio (CEO Sang Hoon Lee), a company specializing ... PCR assay to address the spread of the mpox virus variant, Clade Ib, which is currently prevalent in Africa. Seegene Inc. (KQ096530 ...

Harrington Prize for Innovation in Medicine has been awarded to Owen N. Witte, MD, Distinguished University Professor and President's Chair in Developmental Immunology, David Geffen School of Medicine ...

A Chinese team of virologists has found that this virus carries the risk of animal-to-human transmission. According to the South China Morning Post (SCMP), the new virus called HKU5-CoV-2 was ...

A newly discovered bat coronavirus, HKU5-CoV-2, similar to the virus that caused the COVID-19 pandemic, has been identified in China. The discovery was made by a team of virologists led by Shi ...

In the early, uncertain days of the coronavirus pandemic, scientists delivered one comforting pronouncement: The virus that caused COVID mutates rather slowly. If that remained true, the virus ...

The virus, HKU5-CoV-2, does not enter human cells as readily as SARS-CoV-2, which causes COVID-19, the scientists reported in the journal Cell. However, they found that the bat virus uses the same ...

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells using the same gateway as the virus that causes Covid-19. This virus hasn ...

ORLANDO, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- Abacus Life (NASDAQ: ABL), a leader in the alternative asset management space, today announced it has rebranded to Abacus Global Management ...

Alvogen Pharma US, Inc. ("Alvogen" or the "Company"), a privately owned US-based pharmaceutical company, announced the successful completion of a comprehensive refinancing of its capital structure.